Dcgi(Search results - 6)
India16, Sep 2020, 8:57 AM
Coronavirus: SII gets DCGI nod to recommence clinical trials of Oxford COVID-19 vaccine
AstraZeneca had earlier paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness. It was reported that the clinical trial had been put on hold in the US, UK, Brazil and South Africa.
India12, Sep 2020, 12:43 PM
Coronavirus: DCGI orders SII to suspend new recruitment for Oxford's COVID-19 vaccine trials
The Drugs Controller General Of India (DCGI) has also directed the Serum Institute of India (SII) to increase the safety monitoring of the subjects who have already been vaccinated as part of the trial and submit the plan and report.
India10, Sep 2020, 11:40 AM
SII says ‘will abide by DCGI instructions’ after drug regulator issues notice over continuing vaccine trial
The DCGI issued a show-cause notice to Serum Institute of India (SII) seeking an explanation as to why the ongoing clinical trial of Covishield vaccine has not been paused in India.
India9, Sep 2020, 1:16 PM
Coronavirus: Dr Reddy’s launches Remdesivir for COVID-19 treatment in India
Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of COVID-19 patients hospitalized with severe symptoms.
India3, Aug 2020, 9:04 AM
Coronavirus: DCGI nod to Serum Institute of India for phase 2, 3 human trials of Oxford vaccine candidate
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa
India4, Jul 2020, 12:22 PM
ICMR aims to launch indigenous COVID-19 vaccine by August 15
COVID-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the DCGI